CA
NZ
UK
AU
IND
US
Astrotech's recent strategic pivot reads like a collision between two irreducibleInvestmentnarratives. The company's board approved a lunar resource development initiative targeting silicon-28 and helium-3, materials critical to quantum computing and advanced semiconductorManufacturing. This positioning mirrors the supply-chain logic that propelled Nvidia and Qualcomm to …
The U.S. Trade Representative has proposed additional import duties of 10% to 12.5% on goods from 60 economies, following a determination that all of them have failed to adopt or meaningfully enforce a prohibition on trade in goods produced with forced labor. The action …
Wednesday brought the latest iteration of a conflict that has now outlasted three months of incomplete ceasefires and inconclusive negotiations. Iranian ballistic missiles aimed at Kuwait fell short or broke apart in flight. Three missiles targeting Bahrain were intercepted by U.S. and Bahraini air …
Demand Rebounds, But Employers Hesitate to Commit
A Funding Round That Redraws the Map
Bitcoinslides to its lowest level since early April, dropping over 5% to the mid-US$67,000s as five distinct bearish catalysts converge: Strategy'sDividend-driven BTC sale, record ETF outflows, Mt. Gox wallet movements, a Tether reserve transfer, and renewed US-Iran geopolitical risk.Key HighlightsBitcoin dropped over 5% to …
President Donald Trump on Tuesday named Bill Pulte, director of the Federal Housing Finance Agency, as acting director of national intelligence, handing oversight of the entire US spy apparatus to a 38-year-old with no background in intelligence, defence, or national security. The appointment, announced …
Aditxt Inc. exemplifies a peculiar dynamic in biotechnology markets: the dramatic repricing of near-extinct companies following genuine regulatory or commercial validation. The company's 24.25% pre-market surge, attributed to likely FDA clearance of an Investigational New Drug (IND) filing, reveals how investors oscillate between dismissing …
Zhongchao Inc. exemplifies the terminal decline of a micro-cap healthcare company caught between multiple systemic pressures. The Chinese medical education platform operator has seen its equity value evaporate at a pace that leaves noMarginfor operational recovery. A single-day drop of 53.29% signals not normalVolatilitybut …
WOK Medical Technology Group Ltd presents an unusual case study in market dysfunction. A company trading at $0.109 per share with a market capitalisation of merely $132,900 attracted 388.29 million shares in a single regular session, pushing the daily gain to 15.47%. This volume-to-capitalisation …
Please wait processing your request...